Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 116.45 USD 2.49%
Market Cap: 632.3m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mesa Laboratories Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Accounts Receivables
$40.2m
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
13%
Becton Dickinson and Co
NYSE:BDX
Accounts Receivables
$3B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Accounts Receivables
$2.5B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Accounts Receivables
$3.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Accounts Receivables
$6.9B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Receivables
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
16%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
631.1m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
120.98 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Accounts Receivables?
Accounts Receivables
40.2m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Accounts Receivables amounts to 40.2m USD.

What is Mesa Laboratories Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
13%

Over the last year, the Accounts Receivables growth was 11%. The average annual Accounts Receivables growth rates for Mesa Laboratories Inc have been 21% over the past three years , 27% over the past five years , and 13% over the past ten years .

Back to Top